New drug-pricing system upsets drugmakers

Korean pharmaceutical companies are now dumbfounded by the government’s bold plan to uproot rampant illegal rebate activities in the pharmaceutical industry.

Under the plan, the government will pay medical institutions and drug stores to buy cheaper drugs. The plan is to pay the difference between the price paid and the government-set price limit for the drugs when buyers report drug purchas...